Appendix Table 4.
Region | Women | Men | ||||
---|---|---|---|---|---|---|
Studies, n | RH (95% CI) for All-Cause Mortality 1 Year After Hip Fracture | P Value* | Studies, n | RH (95% CI) for All-Cause Mortality 1 Year After Hip Fracture | P Value* | |
All studies included* | <0.001 | <0.001 | ||||
Americas | 7 | 2.55 (1.96–3.30) | 6 | 3.27 (2.85–3.75) | ||
Europe | 13 | 2.90 (2.52–3.34) | 10 | 3.76 (3.20–4.42) | ||
Southeast Asia | 1 | 2.29 (0.79–6.63) | – | – | ||
Western Pacific (Australia)† | 1 | 6.09 (4.37–8.48) | 1 | 8.78 (6.05–12.76) | ||
Outlying study omitted† | 0.64 | 0.19 | ||||
Americas | 7 | 2.55 (1.96–3.30) | 6 | 3.27 (2.85–3.75) | ||
Europe | 13 | 2.90 (2.52–3.34) | 10 | 3.76 (3.20–4.42) | ||
Southeast Asia | 1 | 2.29 (0.79–6.63) |
RH = relative hazard.
Between-group heterogeneity.